A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis
Conditions
Interventions
- DRUG: CNTX-4975-05
- DRUG: Qutenza
- DRUG: Lidocaine (without epinephrine)
Sponsor
Centrexion Therapeutics